Cronos Group (TSE:CRON) Shares Up 0.3% – Still a Buy?

Shares of Cronos Group Inc. (TSE:CRON) shot up 0.3% on Friday . The stock traded as high as C$3.76 and last traded at C$3.76. 81,193 shares were traded during trading, a decline of 60% from the average session volume of 200,658 shares. The stock had previously closed at C$3.75.

Cronos Group Stock Performance

The company has a debt-to-equity ratio of 0.17, a current ratio of 24.24 and a quick ratio of 24.01. The stock’s 50-day moving average price is C$3.61 and its 200-day moving average price is C$3.34. The company has a market cap of C$1.44 billion, a P/E ratio of 34.18, a PEG ratio of 0.12 and a beta of 1.30.

Cronos Group (TSE:CRON) last released its quarterly earnings results on Thursday, November 6th. The company reported C$0.07 EPS for the quarter. The business had revenue of C$50.60 million for the quarter. Cronos Group had a negative net margin of 42.65% and a negative return on equity of 4.40%. Equities analysts anticipate that Cronos Group Inc. will post -0.26 EPS for the current year.

About Cronos Group

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S.